In a recent trial and appeal, Connolly Bove successfully sustained Pfizer's basic patent and its term extension to preserve Pfizer's exclusivity over Lipitor®.
Press Releases
01|18|2010
01|04|2010
12|21|2009
12|18|2009
11|16|2009


